Article
Publicly Available
Frontmatter
Published/Copyright:
November 30, 2021
Published Online: 2021-11-30
Published in Print: 2021-12-20
©2021 Walter de Gruyter GmbH, Berlin/Boston
Articles in the same Issue
- Frontmatter
- Review Article
- Calcitonin and complementary biomarkers in the diagnosis of hereditary medullary thyroid carcinoma in children and adolescents
- Original Articles
- Genotype and phenotypic spectrum of vitamin D dependent rickets type 1A: our experience and systematic review
- Questioning the adequacy of standardized vitamin D supplementation protocol in very low birth weight infants: a prospective cohort study
- Growth hormone replacement therapy: is it safe to use in children with asymptomatic pituitary lesions?
- Comparing adolescent self staging of pubertal development with hormone biomarkers
- Reverse circadian glucocorticoid treatment in prepubertal children with congenital adrenal hyperplasia
- The concordance between ultrasonographic stage of breast and Tanner stage of breast for overweight and obese girls: a school population-based study
- Cross-sectional analysis: clinical presentation of children with persistently low ALP levels
- The utility of continuous glucose monitoring systems in the management of children with persistent hypoglycaemia
- Long-term effect of conventional phosphate and calcitriol treatment on metabolic recovery and catch-up growth in children with PHEX mutation
- Role of magnetic resonance diffusion weighted imaging in diagnosis of diabetic nephropathy in children living with type 1 diabetes mellitus
- Investigation of quality of life in obese adolescents: the effect of psychiatric symptoms of obese adolescent and/or mother on quality of life
- Predictive value of WHO vs. IAP BMI charts for identification of metabolic risk in Indian children and adolescents
- Case Reports
- COVID-19 triggered encephalopathic crisis in a patient with glutaric aciduria type 1
- Aromatase deficiency in an Ontario Old Order Mennonite family
- A case of monogenic diabetes mellitus caused by a novel heterozygous RFX6 nonsense mutation in a 14-year-old girl
Articles in the same Issue
- Frontmatter
- Review Article
- Calcitonin and complementary biomarkers in the diagnosis of hereditary medullary thyroid carcinoma in children and adolescents
- Original Articles
- Genotype and phenotypic spectrum of vitamin D dependent rickets type 1A: our experience and systematic review
- Questioning the adequacy of standardized vitamin D supplementation protocol in very low birth weight infants: a prospective cohort study
- Growth hormone replacement therapy: is it safe to use in children with asymptomatic pituitary lesions?
- Comparing adolescent self staging of pubertal development with hormone biomarkers
- Reverse circadian glucocorticoid treatment in prepubertal children with congenital adrenal hyperplasia
- The concordance between ultrasonographic stage of breast and Tanner stage of breast for overweight and obese girls: a school population-based study
- Cross-sectional analysis: clinical presentation of children with persistently low ALP levels
- The utility of continuous glucose monitoring systems in the management of children with persistent hypoglycaemia
- Long-term effect of conventional phosphate and calcitriol treatment on metabolic recovery and catch-up growth in children with PHEX mutation
- Role of magnetic resonance diffusion weighted imaging in diagnosis of diabetic nephropathy in children living with type 1 diabetes mellitus
- Investigation of quality of life in obese adolescents: the effect of psychiatric symptoms of obese adolescent and/or mother on quality of life
- Predictive value of WHO vs. IAP BMI charts for identification of metabolic risk in Indian children and adolescents
- Case Reports
- COVID-19 triggered encephalopathic crisis in a patient with glutaric aciduria type 1
- Aromatase deficiency in an Ontario Old Order Mennonite family
- A case of monogenic diabetes mellitus caused by a novel heterozygous RFX6 nonsense mutation in a 14-year-old girl